Safety and efficacy of Rituximab in refractory pediatric systemic lupus erythematosus nephritis: A single-center experience of Northern Greece

Rheumatology International

Volumn 33, Issue 3, 2013, Pages 809-813

  Trachana, Maria ^a   Koutsonikoli, Artemis ^a   Farmaki, Evagelia ^a   Printza, Nikoleta ^a   Tzimouli, Vasiliki ^a   Papachristou, Fotios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Lupus nephritis; Pediatric SLE; Rituximab; Treatment

Indexed keywords

AZATHIOPRINE; CHLORPHENIRAMINE; CYCLOPHOSPHAMIDE; CYSTATIN C; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; RITUXIMAB;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHILD; CHILDHOOD DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EUROPEAN CONSENSUS LUPUS ACTIVITY MEASUREMENT; FOLLOW UP; GREECE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REFRACTORY PERIOD; REMISSION; SCHOOL CHILD; URINARY EXCRETION;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; CHILD; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE;

EID: 84879688320     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2239-6     Document Type: Article

References (25)

1. Papadimitraki ED, Isenberg DA (2009) Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 5:391-403
2. Sousa E, Isenberg D (2009) Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies. Best Pract Res Clin Rheumatol 23:563-574
3. Marks SD, Tullus K (2010) Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis. Acta Paediatr 99:967-974
4. García-Carrasco M, Jiménez-Hernández M, Escárcega RO et al (2009) Use of Rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev 8:343-348
5. Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA (2009) Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases. Lupus 18:767-776
6. Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J (2007) Six refractory lupus patients treated with Rituximab: a case series. Arthr Rheum 57:538-542
7. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 40:1725
8. Brunner HI, Silverman ED, Bombardier C, Feldman BM (2003) European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. Arthr Rheum 49:335-341
9. Weening JJ, D'Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241-250
10. Roos JF, Doust J, Tett SE, Kirkpatrick CM (2007) Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem 40:383-391
11. Pepper R, Griffith M, Kirwan C et al (2009) Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids. Nephrol Dial Transplant 24:3717-3723
12. Willems M, Haddad E, Niaudet P et al (2006) Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 148:623-627
13. Saito K, Nawata M, Nakayamada S, Tokunaga M, Tsukada J, Tanaka Y (2003) Successful treatment with anti-CD20 monoclonal antibody (Rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement. Lupus 12:798-800
14. Vigna-Perez M, Hernández-Castro B, Paredes-Saharopulos O et al (2006) Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthr Res Ther 8:R83
15. Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M et al (2010) Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients. Lupus 19:213-219
16. Lu TY, Ng KP, Cambridge G et al (2009) A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthr Rheum 61:482-487
17. Terrier B, Amoura Z, Ravaud P et al (2010) Safety and efficacy of Rituximab in systemic lupus erythematosus: results from 136 patients from the French Autoimmunity and Rituximab registry. Arthr Rheum 62:2458-2466
18. Podolskaya A, Stadermann M, Pilkington C, Marks SD, Tullus K (2008) B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child 93:401-406
19. Marks SD, Patey S, Brogan PA et al (2005) B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthr Rheum 52:3168-3174
20. Marks SD, Tullus K (2006) Successful outcomes with Rituximab therapy for refractory childhood systemic lupus erythematosus. Pediatr Nephrol 21:598-599
21. Iwata S, Saito K, Tokunaga M et al (2011) Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B Cell Depletion therapy with Rituximab. J Rheumatol 38:633-641
22. Anolik JH, Barnard J, Owen T et al (2007) Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthr Rheum 56:3044-3056
23. Liossis SN, Sfikakis PP (2008) Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol 127:280-285
24. Boletis JN, Marinaki S, Skalioti C, Lionaki SS, Iniotaki A, Sfikakis PP (2009) Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study. Nephrol Dial Transplant 24:2157-2160
25. Ramos-Casals M, Díaz-Lagares C, Khamashta MA (2009) Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al. Arthritis Rheum 61:1281-1282